India’s E-Plan To Map Drug Sales – Turning Point For Better Traceability?
A government plan aimed at putting in place an e-platform to regulate the sale of medicines in India, is expected to bolster end-to-end traceability and help lower the risk of fake drugs in the supply chain. But the platform’s proposed revenue model appears to be a sticking point, at least for now, among other tricky areas.
You may also be interested in...
India’s draft e-pharmacy rules put in place a series of checks and balances to ensure that only genuine e-pharmacies engage in online sales of medicines. Registration and strict record keeping requirements, among other aspects, are mandated under the rules, though it may take a “leap of faith” when it comes to security of patient data, some experts say.
India has deferred the implementation of its track and trace system for pharmaceutical exports - measures that are essentially aimed at curbing the menace of fake products and also enhance supply-chain safety1.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.